Nitric Oxide Modulates the Acute Increase of Gastrointestinal Transit Induced by Endotoxin in Rats: a Possible Role for Tachykinins

Because of the evidence that endogenous nitric oxide (NO) plays an essential role in the physiological regulation of gastrointestinal motility we have investigated, by use of the NO synthase inhibitor, N^G-nitro-l -arginine methyl ester (l -NAME), the role of endogenous NO in the acute endotoxin-induced changes of gastrointestinal transit. Pre-treatment with E. coli endotoxin (100 μg kg^?, i.v.) induced a significant increase in the gastrointestinal transit of a charcoal suspension in anaesthetized rats. Previous administration of the NO synthase inhibitor, l -NAME (10 mg kg^?, i.v.) significantly prevented the effects of endotoxin. l -arginine (200 mg kg^?, i.v.) and the substance P antagonist [d -Pro², d -Trp^7,9]-substance P (SPA), significantly reversed the effects of l -NAME on gastrointestinal transit in rats treated with endotoxin. Pre-treatment with dexamethasone (5 mg kg^?, s.c., twice), an inhibitor of the expression of inducible NO synthase, did not affect the increase in the gastrointestinal transit through constitutive NO synthesis. The results suggest that constitutive nitric oxide is involved in the increase of gastrointestinal transit induced by endotoxin and that the reduction in transit induced by l -NAME in endotoxin-treated rats is mediated by endogenous tachykinins.     

URINARY NO3− EXCRETION AS AN INDICATOR OF NITRIC OXIDE FORMATION IN VIVO DURING ORAL ADMINISTRATION OF l-ARGININE OR l-NAME IN RATS

• 1 Endothelium-derived nitric oxide (NO), a major modulator of vascular tone, is synthesized from the terminal guanidino nitrogen of l -arginine. This reaction is inhibited by analogues of l -arginine, such as N-nitro-l -arginine methyl ester (l -NAME). Many of the biological effects of NO are mediated by the second messenger cGMP. NO is rapidly oxidized to NO₃^? which, like cGMP, is eliminated via excretion into the urine. In a placebo controlled study, we investigated whether oral bolus administration of l -arginine and l -NAME affects the urinary excretion rates of NO₃^? and cGMP in Munich Wistar Frömmter (MWF) rats.
• 2 Twenty MWF rats were kept in metabolic cages and received l -arginine (3 g/kg body weight), l -NAME (50mg/kg), or placebo (0.9% saline) in randomized order. Urine samples were sequentially collected for 10 h and analysed for creatinine, NO₃^? and cGMP.
• 3 l -Arginine induced a slight, but prolonged increase in urine flow, whereas l -NAME induced an early, transient increase in urine flow which was followed by a decrease. Creatinine clearance decreased by 65% after l -NAME, but was not affected by l -arginine or placebo.
• 4 Urinary NO₃^? and cGMP excretion rates transiently increased after l -arginine (NO₃^?: + 29%; cGMP: + 16%) for 4–5h, whereas l -NAME induced an immediate, pronounced and lasting inhibition of urinary NO₃^? and cGMP excretion (NO₃^?:-76%; cGMP:-46%). Urinary NO₃^? and cGMP excretions were significantly correlated (r = 0.755; P< 0.001).
• 5 Urinary excretion rates of NO₃^? and cGMP, expressed as μmol/h, were correlated to urine flow (mL/h; r = 0.617 and 0.649, respectively; both P<0.05), whereas after correction by urinary creatinine (μmol/mmol creatinine) no correlation with urine flow was observed, indicating that these excretion rates were independent of renal excretory function. Thus we conclude that changes in the urinary excretion rates of NO₃^? and cGMP represent changes in NO production rates in vivo when expressed in relation to urinary creatinine. Urinary NO₃^? and cGMP excretion is modulated by acute NO synthase inhibition or substrate provision.

     

A STUDY OF ANGIOTENSIN II RECEPTORS AFTER CHRONIC INHIBITION OF NITRIC OXIDE SYNTHASE IN THE SPONTANEOUSLY HYPERTENSIVE RAT

1. Nitric oxide (NO) synthase inhibition, induces a sustained increase in blood pressure and amplifies the pressor response to infused angiotensin II (AngII). This study was designed to investigate the contribution of AngII receptors to the elevated blood pressure and enhanced pressor response to AngII in the spontaneously hypertensive rat (SHR) chronically treated with N^G-nitro-l -arginine-methyl ester (l -NAME). 2. Two groups of 13 week old female SHR were housed four to a box. Group I rats received l -NAME for 7 days (2.5 mg/kg per day) in their drinking water. Group II rats received water only. Blood pressure was monitored daily by tail-cuff plethysmography. Plasma AngII was measured by radioimmunoassay. Aortic and uterine receptor binding was determined by saturation analysis using [¹²⁵I]-Sar⁸, Ile¹)AngII. Data was analysed using the computer program ligand. 3. Mean systolic blood pressure was significantly elevated in rats treated with l -NAME compared with the control group. Plasma AngII concentration was slightly decreased in rats treated with l -NAME compared with control. Densities of both aortic and uterine AngII receptors increased significantly following NO synthase inhibition. Receptor affinity in the aorta decreased in the l -NAME group compared with control. However, uterine AngII receptor affinity was unchanged. 4. We conclude that the increased blood pressure and enhanced pressor responsiveness that occurs with chronic inhibition of NO synthesis may result partly from increased vascular AngII receptor expression.     

Involvement of nitric oxide in the mediation of NANC inhibitory neurotransmission of guinea- pig trachea

1 The involvement of nitric oxide (NO) in the non-adrenergic non-cholinergic inhibitory (NANC-i) neurotransmission was evaluated in guinea-pigs anaesthetized with chloralose–urethane, using a tracheal pouch preparation. 2 The tracheal pouch, a surgically isolated segment of trachea with intact nerve and blood supply, is an in situ method to demonstrate NANC-i response after complete cholinergic and adrenergic blockade using atropine (5 mg kg^??1) and propranolol (1 mg kg^??1), respectively. Cervical vagi and sympathetic trunks were isolated and cut cranially. The distal ends of the vagi were positioned on bipolar electrodes for subsequent stimulation with 5 V pulses for 2 ms duration at 15 Hz for a total of 90 s. The relaxation response was measured as a pressure drop (cm of H₂O) in the pouch. Each experimental group was composed of six animals. 3 NANC-i responses to two consecutive nerve stimulations at 25 min apart were reproducible. 4 Pouch relaxation responses to electrical nerve stimulations were determined before and after incubation of the pouch with N^ω-nitro-l -arginine methyl ester (l -NAME; 10^??5 m ), a NO synthase (NOS) inhibitor, for 30 min. l -NAME significantly, but not completely, inhibited the NANC-i response of the pouch, suggesting involvement of NO in the NANC-i neurotransmission. 5 The pouch relaxations to vagal stimulations were inhibited significantly after incubation with oxyHb indicating that NO was released. 6 The amount of methaemoglobin (metHb) formed from oxyhaemoglobin (oxyHb) during vagal stimulation was measured by spectrophotometry. Comparison of the values between the control and after nerve stimulation indicated a trend (P = 0.07) toward greater metHb formation in the pouch perfusate after nerve stimulation. 7 NANC-i responses were not significantly inhibited by incubation of the pouch with either of the guanylate cyclase inhibitors, methylene blue or 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). However, a trend toward significance (P ≤ 0.07) was observed. 8 This study demonstrated that NO is involved in NANC-i neurotransmission. However, the findings did not conclusively support the contention that NO is the sole neurotransmitter of NANC inhibition. It is possible that NO produced relaxation of guinea-pig trachea through a cGMP-independent mechanism.     

Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of l-NAME and l-NMMA

Abstract— The anti-nociceptive effect of selective inhibitors of nitric oxide synthase has been assessed in a formalin-induced paw-licking model in mice. l -N^G-Nitro arginine methyl ester (l -NAME) but not l -N^G-monomethyl arginine (l -NMMA) exhibited anti-nociceptive activity in both the early and late phases of paw licking following intraperitoneal administration. The effect on the late phase response was more pronounced. l -NAME (0·1–100 μg) and l -N^G-nitro arginine base (l -NOARG; 10 μg) but not d -NAME (10 μg) were also anti-nociceptive following intracerebroventricular administration. l -NAME (10 μg) administered by this route did not influence locomotor activity. l -NMMA was inactive at doses up to 40 μg by this route. At higher doses (75–200 μg) l -NMMA produced a similar and non-dose related reduction in early/late phase paw-licking time. d -NMMA (100 μg) was inactive. The greater anti-nociceptive effect of l -NAME in this model accords with recently published biochemical data indicating that l -NAME is several orders of magnitude more potent than l -NMMA as an inhibitor of brain nitric oxide synthase. These data support the use of l -NAME as a selective tool to investigate the central pharmacological effects of nitric oxide.     

Characterization of 5-HT receptors mediating contraction and relaxation of the longitudinal muscle of guinea-pig distal colon in vitro

A range of agonists and antagonists were used to characterize the receptors through which 5-hydroxytryptamine (5-HT) contracts and relaxes the longitudinal muscle of segments of guinea-pig distal colon, in vitro. 5-HT contracted the longitudinal muscle over the concentration range 10^–9 to 10^–4 mol/l. The 5-HT3 receptor agonist, 2-methyl-5-HT, produced concentration dependent contractions over the range 10^–6 to 10^–4 mol/l. 5-methoxytryptamine, an agonist at 5-HT4 receptors, caused contractions over a concentration range of 10^–8 to 10^–4 mol/l. The 5-HT4 antagonist, SDZ 205-557 (5 × 10^–7 mol/l) substantially suppressed the responses to low concentrations of 5-HT and to 5-methoxytryptamine, but had no effect on the responses to higher concentrations of 5-HT. In contrast, the 5-HT3 antagonist, granisetron (10^–6 mol/l), blocked the effect of 2-methyl-5-HT and substantially depressed responses to high concentrations of 5-HT, but had no effect on lower concentrations of 5-HT. Granisetron produced a small reduction in the response to 5-methoxytryptamine. Tetrodotoxin (TTX) (3 × 10^–7 mol/l) almost abolished the response to 5-methoxytryptamine and markedly suppressed the response to 2-methyl-5-HT, but the responses to 5-HT were only partially reduced. The 5-HT, antagonist, methiothepin 10^–6 mol/l. depressed the response to 5-HT 10^–7 to 10^–4 mol/l. and blocked its TTX insensitive component. The 5-HT₂ antagonist, ketanserin, in concentrations up to 10^–5 mol/l, had no effect on the contractions evoked by 5-HT.The response to 5-HT was substantially depressed by hyoscine (3 × 10^–6 mol/l. The tachykinin antagonist, spantide 10^–5 mol/l. depressed the response to 5-HT but to a lesser extent than hyoscine. Spantide and hyoscine combined completely blocked the contractile responses to 5-HT Responses to 2-methyl-5-HT were partially suppressed by hyoscine (3 x 10^–6 mol/l. and spantide (10^–5 mol/l) and completely blocked when both byoscine and spantide were present. Contractions evoked by 5-methoxytryptamine were partially blocked by hyoscine (3 × 10^–6 mol/l) and were unaffected by spantide (10^–5 mol/l), but a combination of hyoscine and spantide completely blocked such responses.When the excitatory transmission was blocked with hyoscine (3 × 10^–6 mol/l) and spantide 10^–5 mol/l) and the tone of the muscle raised, an inhibitory response to 5-HT was revealed that had a threshold concentration between 10^–7 mol/l) and 3 × 10^–7 mol/l, and a maximum effect at 10^–4 mol/l. It was blocked by TTX (3 × 10^–7 mol/l) and granisetron 10^–6 mol/l. while N-nitro-l-arginine (NOLA) (10^–4 mol/l) and SDZ 205-557 (5 × 10^–7 mol/l) had no effect. Apamin A 10^–6 mol/l. partially suppressed this response.It is concluded that 5-HT3, 5-HT4 and 5-HT₁-like receptors mediate contraction of the longitudinal muscle of the distal colon. The 5-HT3 and 5-HT4 receptors are located on the excitatory motor neurons innervating the longitudinal muscle and the 5-HT₁-like receptor is located on the muscle. 5-HT3 receptors are also found on inhibitory neurons to the muscle. Correspondence to: D. J. Woollard at the above address     

Response of Rabbit Ear and Femoral Arteries to 5-Hydroxytryptamine During Cooling

The effects of cooling on the response of cutaneous and non-cutaneous arteries to 5-hydroxytryptamine (5-HT) were analysed. Segments 2-mm long from rabbit central ear (cutaneous) and femoral (non-cutaneous) arteries were prepared for isometric tension recording in an organ bath at 37 and 24°C (cooling). 5-HT (10^?9-3 times 10^?4 M) induced concentration-dependent contraction of the arteries. The sensitivity and maximal contraction of ear arteries and only the maximal contraction of femoral arteries to this amine were reduced at 24°C. Endothelium removal or pretreatment with the nitric oxide synthase inhibitor N^G-nitro-l -arginine methyl ester (l -NAME, 10^?5 m ) did not affect the response at 37°C but reversed the decreased sensitivity at 24°C in ear arteries, and neither procedure modified the reactivity at 24 or 37°C in femoral arteries to 5-HT. At both temperatures, the response of ear arteries to 5-HT was shifted to the right by phentolamine (10^?6M) more than by the 5-HT antagonist, ketanserin (3 times 10^?7M), and that of femoral arteries was shifted to the right by ketanserin or the 5-HT₁/5-HT₂ antagonist methysergide (3 times 10^?7 M) more than by phentolamine, in arteries with and without endothelium. These data concur with the proposition that the contraction to 5-HT is mediated mainly by α-adrenergic receptors in ear arteries and mainly by 5-HT-ergic receptors in femoral arteries, and suggest that cooling reduces the sensitivity of cutaneous, but not of deep arteries to 5-HT, probably by endothelium-nitric oxide-dependent mechanisms.     

Protective effect of oral -arginine administration on gentamicin-induced renal failure in rats

We investigated the effects of orally supplemented -arginine, the substrate of nitric oxide (NO) and N^ω-nitro- -arginine methyl ester ( -NAME), a nitric oxide-synthase inhibitor in gentamicin-induced renal failure. Rats were given gentamicin (100 mg/kg/day s.c.), gentamicin and -arginine (2 g/l, drinking water), gentamicin and -NAME (100 mg/l, drinking water) or gentamicin plus -arginine and -NAME. After 8 days, the gentamicin group developed marked renal failure, characterized by a significantly decreased creatinine clearance and increased blood creatinine, fractional excretion of sodium, fractional excretion of lithium, urine gamma glutamyl transferase, systolic blood pressure and daily urine volume when compared to controls. Renal histological analysis confirmed tubular necrosis. -arginine administration caused normalization of these parameters, whereas -NAME led to aggravation of the failure. Concomittant administration of -NAME and -arginine to gentamicin-treated rats caused no significant changes when compared to the rats receiving gentamicin alone. We conclude that -arginine supplementation has beneficial effects in gentamicin-induced renal failure in rats and that these effects are reversed by the NO-synthase inhibitor, -NAME.     

Diuretic effect of NG-nitro-l-arginine methyl ester in the rat

Abstract— Intravenous infusion of the nitric oxide synthase inhibitor N^G-nitro-l -arginine methyl ester, l -NAME (10 μg kg^?1 min^?1), to anaesthetized rats produced a diuresis and natriuresis. By contrast, infusion of the same dose of N^G-nitro-d -arginine methyl ester had no effect on either urine output or sodium excretion. The effects of l -NAME were first evident 120 min after the start of infusion and by 170 min a fivefold increase in urine volume and sodium excretion was recorded. l -NAME also produced a transient fall in inulin clearance and a persistent decline in renal blood flow. These renal effects of l -NAME were associated with a gradual elevation of mean arterial blood pressure, although this only attained statistical significance, in comparison with saline-infused animals, 170 min after the start of infusion. The findings indicate the diuresis and natriuresis evoked by l -NAME in the rat is a result of a direct tubular action together with a pressure diuresis.     

Possible involvement of l-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats

To evaluate whether the l-arginine-nitric oxide (NO) pathway is involved in the regulation of regional blood flow to brown adipose tissue (BAT), the effects of two specific NO synthase inhibitors, N^G-nitro-l-arginine methyl ester (l-NAME) and N^G-monomethyl-l-arginine (l-NMMA), on the blood flow to interscapular brown adipose tissue (IBAT) were studied in urethane-anesthetized rats. Regional blood flow in MAT was measured with laser-Doppler flowmetry.An intravenous injection of l-NAME and l-NMMA, but not of either d-enantiomer, caused a transient and dose-dependent increase in IBAT blood flow. Dose-response curves for these NO synthase inhibitors showed that l-NAME was more potent than l-NMMA in increasing IBAT blood flow. We also observed a concomitant pressor effect accompanied by a slight decrease in heart rate following intravenous injection of l-NAME and l-NMMA. An elevation of IBAT blood flow and blood pressure induced by both l-NAME and l-NMMA was reversed by l-arginine in an enantiomerically specific manner. The increase in IBAT blood flow induced by NO synthase inhibitors was of shorter duration and less sensitive to l-arginine than the increase in blood pressure.Our results show that the WAY blood flow is increased by inhibition of NO synthase and that the response of IBAT vasculature to NO synthase inhibitors is different from that of the resistance vessels which regulate blood pressure. The involvement of l-arginine-NO pathways in modulating microcirculation in IBAT is suggested. Correspondence to: Y. Uchida at the above address     

The role of nitric oxide in serotonin-induced relaxations in the canine terminal ileum and ileocolonic junction

Summary The role of nitric oxide (NO) in 5-HT-induced non-adrenergic non-cholinergic (NANC) relaxations was studied on circular muscle strips of the canine ileocolonic junction (ICJ) and terminal ileum. During an acetylcholine-induced contraction, NO (10^–5 M) evoked a transient relaxation, whereas 5-HT (10^–4 M) caused an initial NANC relaxation followed by a contraction. This initial relaxation to 5-HT, but not the relaxation to NO, was significantly inhibited by the stereospecific inhibitors of the NO biosynthesis N^G-monomethyl-Larginine (L-NMMA) and N^G-nitro-Irarginine (L-NNA). Larginine, but not D-arginine, prevented the inhibitory effect of L-NMMA and LNNA. The enantiomer of L-NMMA, D-NMMA, had no effect. Hemoglobin abolished the NO-induced relaxations and significantly inhibited the relaxation to 5-HT.From these experiments it is concluded that the 5-HT-induced NANC relaxation is mediated by NO or a NO releasing substance.Research Assistant of the National Fund for Scientific Research Belgium (NFWO) Send offprint requests to Y.M. Van Maercke at the above address     

The Protective Effect of Glycine in Cisplatin Nephrotoxicity: Inhibition with NG-Nitro-l-arginine Methyl Ester

Abstract— The effect of glycine on the acute changes in renal haemodynamics and nephrotoxicity produced by cisplatin was investigated in the rat. Cisplatin (6·0 mg kg^?1, i.v.) injection in anaesthetized rats produced, over a period of 2 h, falls of approximately 50% in renal blood flow (RBF) and the clearance of [³H]inulin (CL_IN), effects which were prevented by co-administration of glycine (1·0 g kg^?1). Infusion of the nitric oxide (NO) synthase-inhibitor N^G-nitro-l -arginine methyl ester, l -NAME (10 μg min^?1 kg^?1, i.v.), abolished glycine's ability to maintain RBF in cisplatin-injected rats whilst partially inhibiting the ability of glycine to preserve CL_IN. Treatment of cisplatin-injected rats with glycine (1·0 g kg^?1, i.v.) significantly ameliorated the nephrotoxic effects of cisplatin (6·0 mg kg^?1) as judged by improvements in a range of indices of renal function which included plasma urea and creatinine concentrations, urine output, sodium excretion, CL_IN and the clearance of [¹⁴C]p-aminohippurate. Administration of l -NAME (1·0 mg kg^?1, i.v.) to rats which received cisplatin and glycine significantly inhibited the reno-protective effect of glycine. However, l -NAME administration to rats which were treated only with cisplatin did not result in any potentiation of cisplatin nephrotoxicity. The findings of this study suggest that glycine can block the acute falls in RBF and C_IN produced by cisplatin by a mechanism which involves the production of NO. Furthermore, the results indicate that these renal haemodynamic actions of glycine are responsible, at least in part, for the ability of this amino acid to ameliorate cisplatin nephrotoxicity.     

Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors

1. Arginine-vasopressin (VP) has both vasoconstricting and vasodilating action. We report here the discovery of four novel selective hypotensive VP analogues: d(CH₂)₅[D-Tyr(Et)²,Arg³,Val⁴]AVP; d(CH₂)₅[D-Tyr(Et)²,Lys³,Val⁴]AVP and their iodinatable Tyr-NH₂⁹ analogues.
2. Bioassays in rats for activities characteristic of neurohypophysial peptides showed that the four VP peptides possessed little or no V_1a, V₂ or oxytocin (OT) receptor agonistic or antagonistic activities.
3. In anaesthetized rats, these peptides (0.05–0.10 mg kg⁻¹ i.v.) elicited a marked fall in arterial blood pressure.
4. Blockade of cholinoceptors, adrenoceptors and bradykinin B₂ receptors, and inhibition of prostaglandin synthesis had little effect on their vasodepressor action.
5. Classical V_1a, V₂ and OT receptor antagonists did not block the vasodepressor response.
6. L-NAME, 0.2 mg kg⁻¹ min⁻¹, markedly suppressed the hypotensive response to ACh but not the vasodepressor response to the hypotensive VP peptides. However, the duration of the vasodepressor response was shortened. Very high doses of L-NAME attenuated both the vasodepressor response and the duration of action.
7. These findings indicate that the vasodepressor action of these VP peptides is independent of the peripheral autonomic, bradykinin and PG systems and is not mediated by the known classical OT/VP receptors. NO does not appear to have an important role in their vasodepressor action.
8. The discovery of these novel VP peptides could lead to the development of new tools for the investigation of the complex cardiovascular actions of VP and the introduction of a new class of hypotensive agents. The two iodinatable hypotensive VP peptides could be radiolabelled as potential markers for the localization of the receptor system involved.

     

Bombesin-induced contractions of guinea pig lung strips are modulated by endogenous nitric oxide

We have investigated the effects of a nitric oxide (NO) biosynthesis inhibitor N^\sw-nitro-L-arginine methyl ester (l-NAME) on the bombesin-evoked contraction of guinea pig parenchymal lung strips. The bombesin-induced contractions of lung strips were significantly increased after l-NAME (300 M) pre-treatment. The maximal response was increased (P < 0.01) by 37% after l-NAME treatment when compared with the control group. The pD₂ value was not influenced by l-NAME pre-treatment. The enhancement of the bombesin-induced contraction caused by l-NAME was reversed by addition of an excess of the NO precursor-l-arginine (600 M) but not by the addition of its inactive enantiomer d-arginine (600 M). Like l-NAME, methylene blue (1 M), an agent that inhibits the soluble guanylyl cyclase activated by NO, significantly increased (P < 0.01) the maximal contraction induced by bombesin (183 ± 16 mg) when compared with the control group (141 ± 15 mg). When tested against other agonist-induced contractions, l-NAME did not change the responsiveness of parenchymal lung strips to bradykinin or carbachol but significantly increased the lung contraction induced by histamine. NO synthesis inhibition resulted in a pronounced increase in the bombesin-induced contraction of guinea-pig lung strips. Our results suggest that bombesin contributes to NO synthesis and release which then acts to reduce the contraction of the lungstrip in response to bombesin.     

A component of 5-HT-evoked depolarization of the rat isolated vagus nerve is mediated by a putative 5-HT4 receptor

Summary This study describes a component of 5-HT-evoked depolarization of the rat isolated vagus nerve which was unaffected by the 5-HT₃ receptor antagonist ondansetron. A grease-gap extracellular recording technique was used. Ondansetron (10–100 nmol/1) displaced the 5-HT concentration-response curve to the right yielding a pA₂ value of 8.6 (8.5–8.8), consistent with 5-HT₃ receptor antagonism, and revealing a component of the 5-HT response which was resistant to ondansetron blockade. In the presence of ondansetron (100 nmol/1) the maximum depolarization in the resistant phase was 15.5 (12.6–19.2)% of the initial maximum response to 5-HT and the pEC₅₀ value was 7.0 (6.7–7.3). The mechanism of the ondansetron-resistant component of the 5-HT response resembled a 5-HT₄ -receptor-effect in being absent in preparations equilibrated with 5-methoxytryptamine (10 mol/1) and antagonised by ICS 205930 (tropisetron, pA₂ 6.4). 5-Methoxytryptamine alone was an agonist in the vagus nerve with a maximum response similar to that of the ondansetron resistant phase of the 5-HT response. similarly renzapride alone evoked small depolarizations of this preparation but antagonized the ondansetron resistant phase of the 5-HT response (pA₂ 7.3–7.4). These effects of 5-methoxytryptamine and renzapride are also consistent with a 5-HT₄ receptor mechanism. Ketanserin (1 mol/1) and methysergide (1 mol/1) had little effect on responses to 5-HT. The depolarization evoked by this putative 5-HT₄ receptor mechanism was small but prolonged and appears to mask and after-hyperpolarizing phase of the 5-HT response in this tissue. Correspondence to: K. F. Rhodes at the above address     

N-nitro- -arginine methylester is protective against ethanol-induced gastric damage in cholestatic rats

In this study the effect of nitric oxide (NO) synthesis inhibition on ethanol-induced gastric damage was evaluated in bile duct-ligated, sham-operated and unoperated rats. The animals were injected intraperitoneally with saline, -arginine (200 mg/kg) or N^G-nitro- -arginine methylester ( -NAME) in doses of 5, 15 and 30 mg/kg, 30 min before ethanol administration. The animals were killed 1 h after ethanol administration and their stomachs were removed for measurement of gastric mucosal damage. The results showed that -NAME significantly enhanced the development of gastric mucosal lesions in sham-operated and unoperated rats, while in bile duct-ligated animals, -NAME decreased and -arginine enhanced the potentiation of ethanol-induced gastric mucosal damage. The plasma level of nitrite and nitrate was also measured and was significantly higher in bile duct-ligated rats than in control groups. The results suggest that inhibition of NO synthase with -NAME has different effects on ethanol-induced gastric damage in cholestatic groups and in normal rats and that these effects can be explained by overproduction of NO in bile duct-ligated animals.     

Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats

Rationale Nitric oxide (NO) is implicated in the acute locomotor activating effects of some addictive drugs such as amphetamine, caffeine, and PCP, but has not been investigated in the case of toluene.Objectives This study determined the contribution of the NO-cyclic GMP (cGMP) pathway to locomotor stimulant effects of toluene.Methods Locomotor activity was measured for 90 min immediately following toluene (500–1,000 mg/kg, IP) or corn oil treatments in Sprague-Dawley female rats. A NO generator, sodium nitroprusside (SNP) (3 and 6 mg/kg), a NO precursor, l-arginine (l-Arg) (250 mg/kg), a NO synthase inhibitor,N^G-nitro-l-arginine methyl ester (l-NAME) (5–20 mg/kg, IP), and a soluble guanylyl cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 mg/kg) were injected 5 min before toluene (750 mg/kg, IP) treatment. The combination effects of SNP with l-NAME, l-arginine with l-NAME, SNP with ODQ and l-arginine with ODQ on toluene-induced locomotor hyperactivity were also determined.Results The locomotor hyperactivity induced by toluene was significantly inhibited by SNP and l-arginine, but enhanced by l-NAME and ODQ. SNP and l-arginine completely reversed the combined effects of l-NAME and toluene to a basal level and abolished the enhancing effects of ODQ.Conclusions The results suggested that NO/cGMP-dependent mechanism might be involved in toluene-induced locomotor activity in rats.     

NG-Nitro-l-arginine methyl ester inhibits the effect of an H3-histaminergic receptor agonist on NANC contraction in guinea-pig perfused bronchioles

Abstract— A role for nitric oxide in the H₃-histaminergic agonist-induced inhibition of the non-adrenergic, non-cholinergic (NANC) contraction has been studied in guinea-pig perfused bronchioles. (R)-α-Methylhistamine ((R)-α-MeHA), an agonist for H₃ receptors, inhibited the NANC contraction induced by electrical field stimulation. N^G-Nitro-l -arginine methyl ester (l -NAME) (50 μm ), an inhibitor of nitric oxide synthesis, blocked the effect of (R)-α-MeHA. The effect of l -NAME was reversed by l -arginine (50 μm ). l -NAME, l -arginine or (R)-α-MeHA were without effect on exogenous substance P- or neurokinin A-induced contractile responses of the perfused bronchioles. These results show that an H₃-agonist inhibited the release of neurotransmitters in NANC nerve endings of guinea-pig perfused bronchioles presumably by production of nitric oxide.     

一氧化氮合酶抑制剂(L-NAME)的药理作用与慢性血管效应

目的：探讨N^ω-硝基L-精氨酸甲酯(L-NAME)对不同动脉的慢性血管效应及其与抑制内皮依赖性一氧化氮(EDNO)合成的关系。方法：采用大鼠离体动脉环的张力测定,一氧化氮合酶活性测定及组织学、生化学等方法。结果：给药8周后大鼠尾动脉压明显升高、体重及胸主动脉的内皮依赖性舒张功能明显下降并释放内皮依赖性收缩因子,肠系膜微动脉的内皮依赖性舒张功能无改变。给药8周后出现了动脉中膜肥厚及其周围纤维化。N^ω-硝基D-精氨酸甲酯(D-NAME)的慢性给药亦可引起与L-NAME同样的动脉周围纤维化。结论：L-NAME对大鼠胸主动脉及肠系膜微动脉的作用不同,其慢性血管效应与抑制EDNO合成以外的其它机制相关。     

Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin

In order to test the hypothesis that a 5-hydroxytryptamine (5-HT)-induced increase in vascular permeability results from a cascade triggered by activation of the synthesis of nitric oxide (NO), the vascular permeability was investigated using the Pontamine sky blue leakage method in male mice. Subcutaneous injection of 5-HT induced a dose-related increase of vascular permeability at the injection site. The vascular permeability induced by 5-HT was inhibited by pretreatment with intraperitoneal injection of ketanserin (5-HT_2A antagonist) and methysergide (5-HT_1/2A antagonist), less efficiently by 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine (NAN-190) (5-HT_1A antagonist), but not by granisetron (5-HT₃ antagonist). Increase in vascular permeability induced by 5-HT was inhibited by concurrent intravenous administration of NO synthase inhibitors N^G-nitro-Lrarginine methyl ester (L-NAME) and methylene blue but not by the inactive enantiomer N^G-nitro-D-arginine methyl ester (D-NAME). These results suggest that 5-HT increases vascular permeability by activating the 5-HT receptors and that endogenous NO is involved in this effect of 5-HT. Correspondence to: E. Fujii at the above address